Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer | Citedby Results | Cancer Discovery | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Cancer Discov (2022) 12 (5): 1356–1377.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology

Vijay Kumar
Caitlin Bauer
John H. Stewart

European Journal of Cell Biology (2023) 102 (3): 151338.

Tailoring therapies to counter the divergent immune landscapes of breast cancer

Sherif Attalla
Tarek Taifour
William Muller

Frontiers in Cell and Developmental Biology (2023) 11

Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung

Zhengzheng Zhang
Zhiyan Yao
Zimeng Zhang
Ling Cui
Ling Zhang
Gang Qiu
Xiaotian Song
Shuxia Song

Cancer Cell International (2023) 23 (1)

Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy

Hao Zuo
Mengjie Yang
Qian Ji
Shengqiao Fu
Xi Pu
Xu Zhang
Xu Wang
Paulina Niedźwiedzka-Rystwej

Journal of Immunology Research (2023) 2023: 1.

ENPP1 Immunobiology as a Therapeutic Target

Borja Ruiz-Fernández de Córdoba
Rafael Martínez-Monge
Fernando Lecanda

Clinical Cancer Research (2023) 29 (12): 2184.

Meet the Editorial Board Member

Dominique Heymann

Current Medicinal Chemistry (2023) 30 (31): 3505.

Fibroblast Activation Protein Inhibitor Theranostics

Katharina Lückerath
Marija Trajkovic-Arsic
Christine E. Mona

PET Clinics (2023) 18 (3): 409.

Human antibodies targeting ENPP1 as candidate therapeutics for cancers

Xiaojie Chu
Du-San Baek
Wei Li
Taras Shyp
Brian Mooney
Margaret G. Hines
Gregg B. Morin
Poul H. Sorensen
Dimiter S. Dimitrov

Frontiers in Immunology (2023) 14

PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification

Tianyi He
Xiangyu Sun
Chen Wu
Litong Yao
Yingfan Zhang
Shiyang Liu
Yuhan Jiang
Yixiao Li
Mozhi Wang
Yingying Xu

Cellular Signalling (2023) 112: 110918.

Neutrophil extracellular traps in tumor progression and immunotherapy

Meina Yan
Yifeng Gu
Hongxia Sun
Qinghong Ge

Frontiers in Immunology (2023) 14

Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer

Yue Lou
Peng Peng
Shicheng Wang
Junjun Wang
Peishan Du
Zelu Zhang
Jiamin Zheng
Ping Liu
Lisa X. Xu

Frontiers in Immunology (2022) 13

Neutrophil extracellular traps: New players in cancer research

Junjie Zhao
Jiaqi Jin

Frontiers in Immunology (2022) 13

5′-Chalcogen-Substituted Nucleoside Pyrophosphate and Phosphate Monoester Analogues: Preparation and Hydrolysis Studies

Satu Mikkola
Olga Eguaogie
Anu Nieminen
Patrick F. Conlon
David L. Jakeman
Keith Moore
Ian C. Lane
Joseph S. Vyle

International Journal of Molecular Sciences (2022) 23 (24): 15582.

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

David Repáraz
Marta Ruiz
Leyre Silva
Belén Aparicio
Josune Egea
Elizabeth Guruceaga
Daniel Ajona
Yaiza Senent
Enrique Conde
Flor Navarro
Sergio Barace
Diego Alignani
Sandra Hervás-Stubbs
Juan José Lasarte
Diana Llopiz
Pablo Sarobe

Frontiers in Immunology (2022) 13